Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Alemtuzumab CARE-MS I 5-year follow-up
Neurol 89:1107-1116, Havrdova, E.,et al, 2017
See this aricle in Pubmed

Article Abstract
Based on these data, alemtuzumab provides durable efficacy through 5 years in the absence of continuous treatment, with most patients not receiving additional courses.
 
Related Tags
(click to filter results - removes previous filter)

alemtuzumab
brain atrophy
efficacy
immunomodulation
monoclonal antibodies
MRI,abnormal
multiple sclerosis
multiple sclerosis,relapsing
multiple sclerosis,treatment of
treatment of neurologic disorder

Click Here to return To Results